CD19 and hepatocellular carcinoma: In summary, the obtained data indicated a strong increase in the number of PD-L1+, IL-10+, and IgM+IgD+ CD19+B220+CD138+ PBs in the livers of mice with MASLD and HCC, which correlated with disease severity.